v3.25.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 19,601 $ 39,342
Accounts receivable, net 9,075 7,631
Inventory, net 12,132 14,845
Other current assets 8,696 6,309
Total current assets 49,504 68,127
Property and equipment, net 9,928 6,973
Capitalized software, net 3,582 3,877
Goodwill 5,833 5,833
Intangible assets, net 4,883 5,500
Operating lease right-of-use assets 2,978 3,246
Deferred tax assets, net 28,018 28,742
Other non-current assets 72 72
Total assets 104,798 122,370
Current liabilities    
Accounts payable 3,863 5,813
Accrued expenses 8,983 11,293
Term loan, current 6,250 6,250
Deferred revenue, current 3,052 2,961
Earnout liabilities, current   100
Operating lease liabilities, current 557 523
Share repurchase liabilities, current 27,832 24,574
Total current liabilities 50,537 51,514
Term loan, net of current portion 98,486 101,199
Deferred revenue, net of current portion 1,402 1,553
Operating lease liabilities, net of current portion 2,601 2,890
Share repurchase liabilities, net of current portion 17,947 44,300
Other non-current liability   1,500
TRA liability 4,386 4,479
Earnout liabilities, net of current portion 8,279 17,135
Total liabilities 183,638 224,570
Commitments and contingencies (See Note 19)
Stockholders' Deficit    
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued or outstanding as of June 30, 2025 and December 31, 2024, respectively
Additional paid-in capital 0 0
Accumulated deficit (79,478) (100,297)
Accumulated other comprehensive loss (30) (35)
Treasury stock, at cost (5,600) (5,600)
biote Corp.'s stockholders' deficit (85,104) (105,928)
Noncontrolling interest 6,264 3,728
Total stockholders' deficit (78,840) (102,200)
Total liabilities and stockholders' deficit 104,798 122,370
Class A Common Stock    
Stockholders' Deficit    
Common stock value 3 3
Class V Common Stock    
Stockholders' Deficit    
Common stock value $ 1 $ 1